Literature DB >> 18457051

Analysis of the contribution of molecular mechanisms into formation of gonoccocal resistance to tetracycline.

A D Borovskaya1, M V Malakhova, V A Vereshchagin, E N Il'ina, V M Govorun, T V Priputnevich, N Al-Hafagi, A A Kubanova.   

Abstract

We applied complex genetic analysis for evaluation of tetracycline-resistance markers in 129 clinical strains of Neisseria gonorrhoeae from Central, Privolzhskii, and Siberian regions. For detection of mutations in rpsJ gene and MtrRCDE locus we first used minisequence reaction followed by identification of products by MALDI-TOF mass spectrometry. The incidence of detection of resistance markers among the analyzed strains were: tetM--3.1%, mutations in genes rpsJ--82.2%, penB--62.8%, and mtrR--54.3%. The analyzed genetic markers were not detected in 17.5% strains. tetM gene was detected in only 12.5% strains from the Central Region. No differences were revealed in regional distribution of other genotypes. Genotypes tetM(pres), rpsJ(mut), mtrR(mut), and rpsJ(mut), penB(mut), mtrR(mut) reliably predict tetracycline resistance. Microbiological and genetic testing of tetracycline resistance yielded similar results.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18457051     DOI: 10.1007/s10517-007-0347-9

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

Review 1.  Matrix-assisted laser desorption ionization-time of flight (maldi-tof) mass spectrometry for detection of antibiotic resistance mechanisms: from research to routine diagnosis.

Authors:  Jaroslav Hrabák; Eva Chudácková; Radka Walková
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

2.  Plasmid-mediated resistance to tetracyclines among Neisseria gonorrhoeae strains isolated in Poland between 2012 and 2013.

Authors:  Beata Młynarczyk-Bonikowska; Marlena Kujawa; Magdalena Malejczyk; Grażyna Młynarczyk; Sławomir Majewski
Journal:  Postepy Dermatol Alergol       Date:  2016-12-02       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.